Structure Therapeutics (GPCR) EBT (2022 - 2026)

Structure Therapeutics' EBT history runs 5 years deep, the most recent figure standing at -$75.8 million for Q1 2026.

• In Q1 2026, EBT fell 62.14% year-over-year to -$75.8 million; the TTM figure through Mar 2026 stood at -$25.7 million (up 14.02% YoY), while the FY2025 annual figure was $3.4 million, up 137.22% from the prior year.
• EBT for Q1 2026 stood at -$75.8 million, down from $177.3 million in the prior quarter.
• The five-year high for EBT was $177.3 million in Q4 2025, with the low at -$75.8 million in Q1 2026.
• The 5-year median for EBT is -$23.2 million (2023), against an average of -$5.8 million.
• Peak annual rise in EBT reached 130.9% in 2025, while the deepest fall reached 136.8% in 2025.
• Structure Therapeutics' EBT stood at $32.2 million in 2022, then jumped by 71.04% to $55.1 million in 2023, then jumped by 39.37% to $76.8 million in 2024, then surged by 130.9% to $177.3 million in 2025, then plunged by 142.75% to -$75.8 million in 2026.
• Business Quant data shows GPCR's EBT at -$75.8 million in Q1 2026, $177.3 million in Q4 2025, and -$65.6 million in Q3 2025.